Larkspur to Present New Preclinical R&D Program Candidate at AACR 2024
28 Mar 2024 //
GLOBENEWSWIRE
Larkspur Bio Announces CEO Catherine Sabatos-Peyton to Participate in Events
14 Dec 2023 //
GLOBENEWSWIRE
Larkspur to Present Data on Role of Pin1 in Fibroblast Cancer Axis
25 Oct 2023 //
GLOBENEWSWIRE
Larkspur Announces First-in-Class Program Targeting Novel B Cell Checkpoint
26 Jun 2023 //
GLOBENEWSWIRE
Larkspur Biosciences to Participate in the 2023 BIO International Convention
30 May 2023 //
GLOBENEWSWIRE
Larkspur Biosciences Launches with $35.5 Million in Financing
23 May 2023 //
GLOBENEWSWIRE
Larkspur Bio kicks off with $30M+, hunting for new oncology immunotherapies
23 May 2023 //
ENDPTS